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ABSTRACT OF THESIS 
 
THE ASSOCIATION BETWEEN DISTRESS AND BOTH SOCIAL SUPPORT AND 
SOCIAL CONSTRAINT IN RECENTLY DIAGNOSED CANCER SURVIVORS:  
A DAILY ASSESSMENT STUDY 
 
This study evaluated two distinct aspects of social functioning (specifically, social 
support and social constraint) in an attempt to increase understanding of its bidirectional 
relationship with distress after cancer diagnosis. Participants in this intensive longitudinal 
study were all recently diagnosed, first primary cervical or head/neck cancer survivors 
(n=47). Data collection involved a comprehensive baseline assessment and 30-day period 
of daily assessment (n=37) of key variables (i.e., social support, social constraint, and 
distress). Data were analyzed using unconditional and conditional multilevel linear 
models. None of the variables changed significantly over the 30-day period. On a typical 
day, social constraint and distress were predictive of one another (ps < .001). Social 
support and distress did not demonstrate a bidirectional relationship (ps > .05). In the 
context of cancer adjustment and survivorship, future interventions for distress should 
consider targeting social constraint and interventions for social constraint should consider 
targeting distress. 
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Chapter One: Introduction 
Cancer Epidemiology in the United States 
Every year, more than 1.5 million people will receive a cancer diagnosis in the 
United States (American Cancer Society, 2017). In 2016, more than 15.5 million cancer 
survivors are living in the United States, and this number was expected to grow in 2017 
(American Cancer Society, 2017). Based on data from 2007 to 2013, the rate of 5-year 
survival for all people diagnosed with cancer is 67% (National Cancer Institute, 2017), 
but it should be appreciated that rates of survival differ significantly across both type 
(e.g., breast versus lung) and stage (e.g., Stage IA versus IV) of disease. Regardless of an 
individual’s survival rate, the quality of the cancer survivors’ life is well recognized as an 
important outcome to consider.  
Quality of Life (QOL) 
QOL is a multidimensional concept (Cella & Nowinski, 2002) that includes an 
individual’s perceptions of his or her physical, psychological, spiritual, and social 
functioning (Ferrell & Hassey Dow, 1997). The aforementioned domains or factors 
correspond to different aspects of QOL, all of which are theorized to be interdependent 
(Ferrell & Hassey Dow, 1997). This means that, for example, a change in social 
functioning is likely to cause or co-occur with a change in psychological functioning, and 
vice versa. While there is a paucity of longitudinal research that explores the reciprocal 
relationships among QOL factors (Bloom, Stewart, Johnston, Banks, & Fobair, 2001; 
Ganz et al., 2003; Hagedoorn, Sneeuw, & Aaronson, 2002; Ramchand, Marshall, Schell, 
Jaycox, & Corporation, 2008), there is a sizeable body of cross-sectional research that 
demonstrates significant associations among the factors themselves and/or significant 
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relationships between overall QOL and its underlying factors (for example, see Cotton, 
Levine, Fitzpatrick, Dold, & Targ, 1999; Rippentrop, Altmaier, Chen, Found, & Keffala, 
2005; Wenzel et al., 2005; Zenger et al., 2010). 
Cancer Survivors’ QOL 
Most research suggests cancer survivors report worse QOL than individuals 
without a cancer history (Arndt, Merx, Stegmaier, Ziegler, & Brenner, 2004; Burris & 
Andrykowski, 2011; Jephcott, Paltiel, & Hay, 2004; Lee et al., 2011; LeMasters, 
Madhavan, Sambamoorthi, & Kurian, 2013; Richardson, Wingo, Zack, Zahran, & King, 
2008) though some studies show no significant difference between people with and 
without a cancer history (Bradley, Rose, Lutgendorf, Costanzo, & Anderson, 2006; 
Wettergren, Bjorkholm, Axdorph, Bowling, & Langius-Eklof, 2003). Nonetheless, cancer 
survivors’ QOL (see Figure 1.1) is known to vary across individuals and across time 
(Andrykowski, Lykins, & Floyd, 2008; Helgeson, Snyder, & Seltman, 2004). Some of 
the individual difference variables that explain QOL differences among cancer survivors 
include age (Roland, Rodriguez, Patterson, & Trivers, 2013; So et al., 2012), gender 
(LeMasters et al., 2013), race (Janz et al., 2009), type of diagnosis (Bloom et al., 2001), 
type of treatment (Zeng, Ching, & Loke, 2011), and behavioral factors (Duijts, Faber, 
Oldenburg, Beurden, & Aaronson, 2011; Zeng et al., 2011). Although it seems that most 
cancer survivors’ overall QOL improves with time – even if it does not return to their 
pre-cancer baseline (Andrykowski et al., 2008; Hsu, Ennis, Hood, Graham, & Goodwin, 
2013) – the sub-factors of QOL can show a different pattern of change or no change at all 
(Hsu et al., 2013; Koczywas et al., 2013; So et al., 2012). Thus, the QOL of cancer 
survivors is quite complex.  
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The large body of research on cancer survivors’ QOL includes studies that focus 
on describing the nature and course of one or more individual factors. The literature 
shows that cancer survivors’ overall physical functioning (e.g., nausea, fatigue, and sleep 
problems) may improve after treatment (Bloom, Petersen, & Kang, 2007), but some late 
effects of treatment (e.g., cognitive impairment, pain, and cardiovascular events) can 
occur in this population (Ahles et al., 2002; Kenyon, Mayer, & Owens, 2014). Physical 
functioning is often correlated with psychological functioning (Loeb & Jonas, 2015; 
Ramchand et al., 2008; Wilson & Cleary, 1995), which includes symptoms of anxiety, 
depression, and other indicators of distress 1 as well as positive outcomes like life 
satisfaction (Ferrell, Grant, Funk, Otis-Green, & Garcia, 1998; Wilson & Cleary, 1995). 
Psychological functioning is also known to change over time (Bloom et al., 2007; 
Stiegelis, Ranchor, & Sanderman, 2004), a finding that will be discussed in more depth 
later. Spiritual functioning pertains to the ability to derive meaning from the cancer 
experience, be hopeful, and perceive a sense of purpose in life (Brady, Peterman, Fitchett, 
Mo, & Cella, 1999; Ferrell et al., 1998; Sterba et al., 2014; Wenzel et al., 2005). A study 
of lung cancer survivors’ spiritual needs found that it fluctuates in the last year of life, 
and that spiritual distress is greatly associated with four key events along the cancer 
continuum (specifically, diagnosis, treatment completion, disease progression, and 
terminal illness; Murray et al., 2007). Although this study only included lung cancer 
                                                
 
1 The National Comprehensive Cancer Network defines “distress” as “a multifactorial unpleasant 
emotional experience… that may interfere with the ability to cope effectively with cancer, its physical 
symptoms and its treatment” (National Comprehensive Cancer Network, 2013, pg. DIS-3, emphasis 
added). As “distress” and “psychological distress” are viewed here as interchangeable, “distress” will be 
used for sake of brevity. 
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survivors, it is likely the results may generalize to other cancer survivors. Finally, social 
functioning primarily deals with an individual’s social roles and relationships (Bloom et 
al., 2007; Ferrell, Grant, Funk, Otis-Green, & Garcia, 1997). Social-related concerns 
(e.g., worry about finances or job security, or fear about one’s daughter developing 
cancer) may persist beyond the completion of cancer treatment (Beckjord et al., 2014; 
Ferrell et al., 1997), and may differ by gender, age, race, and ethnicity (Bourjolly, 
Kerson, & Nuamah, 1999; Carver, Smith, Petronis, & Antoni, 2006; Hammerlid & Taft, 
2001). Although prior research largely treats the various QOL factors as unique, it is 
expected that disruption or improvement in one factor will affect one or more of the 
others factors (Bloom et al., 2007), a dynamic relationship that can only be fully tested by 
use of longitudinal research designs. 
Compared to the physical and psychological aspects of cancer survivors’ QOL, 
the spiritual and social aspects have received little attention. In particular, social 
functioning deserves greater clinical and research attention since cancer is a disease that 
affects the whole family, not just the individual who receives the diagnosis (Ballard-
Reisch & Letner, 2003; Edwards & Clarke, 2004; Mantani et al., 2007; Traa, De Vries, 
Bodenmann, & Den Oudsten, 2015). Another reason to better understand the social 
functioning of cancer survivors is because it could explain (at least in part) why other 
aspects of QOL, such as psychological functioning, vary across people and time. Given 
the fact that social functioning is a relatively understudied, but potentially influential 
factor for cancer survivors, it will be the focus herein. 
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Social Functioning I 
Social functioning corresponds to a wide array of social components (e.g., 
occupation/workplace productivity, community engagement, relationship quality, and 
parental, familial, and other social roles; Hirschfeld et al., 2000), and is related to how 
individuals interact with the environment and engage in social relationships (Bosc, 2000). 
Among cancer survivors, various indicators of social functioning demonstrate the ability 
to impact both health behavior and QOL outcomes (Edwards & Clarke, 2004; 
Pasipanodya et al., 2012; Roland et al., 2013). To summarize, studies with cancer 
survivors that show better social functioning is associated with better treatment adherence 
(DiMatteo, 2004), higher levels of physical activity (Mosher et al., 2009), less distress 
(Jim & Andersen, 2007; Mantani et al., 2007; Roland et al., 2013), less physical pain 
(Roland et al., 2013), and better overall health (Roland et al., 2013). Although social 
functioning appears to have a strong influence on important outcomes among cancer 
survivors, a closer look at the extant research shows some inconsistency across studies. 
Some studies have found that cancer survivors have poorer social functioning than the 
general population (Arndt et al., 2004; Efficace et al., 2008; Vironen, Kairaluoma, Aalto, 
& Kellokumpu, 2006) while other studies have not found this difference (Dorval, 
Maunsell, Deschbnes, Brisson, & Masse, 1998; McLarty et al., 1997; van Tulder, 
Aaronson, & Bruning, 1994; Wenzel et al., 2005). Similarly, some studies find social 
functioning improves with time (Chan, Ng, Ngan, & Wong, 2003; King, Kenny, Shiell, 
Hall, & Boyages, 2000) while others do not (Bozec et al., 2008; de Graeff et al., 2000b; 
Ronis, Duffy, Fowler, Khan, & Terrell, 2008). Finally, some studies find social 
functioning is associated with the overall QOL of cancer survivors (Edwards & Clarke, 
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2004; Karnell, Christensen, Rosenthal, Magnuson, & Funk, 2007; Pasipanodya et al., 
2012; Roland et al., 2013; Wenzel et al., 2005), whereas other studies do not find a 
significant association between these variables (Kemmler et al., 1999; King et al., 2000). 
A plausible explanation for all of this inconsistency is that social functioning is a 
multidimensional construct that includes a wide range of domains, not all of which 
operate in the same way or carry the same significance across outcomes (Muzzatti & 
Annunziata, 2012). 
Since social functioning is multidimensional and its various sub-components may 
differentially impact any and all outcomes of interest (Hirschfeld et al., 2000), the 
proposed study will focus not on the broader construct, but on two sub-components 
thought to be particularly important for cancer survivors. Herein, the focus is on the 
social factors of social support and social constraint. By focusing on these factors, the 
proposed study will address both a positive and negative dimension of social functioning 
(social support and social constraint, respectively), and provide important information 
about which specific aspects of social functioning explain the distress of cancer 
survivors.  
Social Functioning II: Social Support 
Definitions and measurement. Social support is normally considered a positive 
dimension of social functioning (Mallinckrodt, Armer, & Heppner, 2012; Nilsson et al., 
2013). Although social support does not have a universally agreed upon definition 
(Uchino, 2006; Walsh & Connelly, 1996), it may be understood as the emotional, 
instrumental, and informational support provided by an individual’s social network 
(Dakof & Taylor, 1990). In addition, in some studies, social support is divided into 
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structural and functional support, where structural support refers to the number of people 
in ones social network and functional support refers to the nature, quality, and function of 
the support components (Nausheen, Gidron, Peveler, & Moss-Morris, 2009). The 
aforementioned variability in definitions and measurement of social support likely 
contributes to a lack of consensus concerning how, for whom, and when social support 
influences other aspects of QOL or any other outcome (Nausheen et al., 2009; Uchino, 
2006). For example, perceived social support in long-term cancer survivors is sometimes, 
but not always related to posttraumatic growth (Schroevers, Helgeson, Sanderman, & 
Ranchor, 2010), and lower perceived social support is more strongly related to colon 
cancer risk in African American men than Caucasian men (Kinney et al., 2003). The 
proposed study will focus on the amount of perceived functional social support since 1) it 
is most consistently related to various aspects of QOL (Luszczynska, Pawlowska, 
Cieslak, Knoll, & Scholz, 2013) and 2) it has a broad research base from which to make 
firm hypotheses. 
Significance. Social support is positively linked to physical functioning 
(Luszczynska et al., 2013) and treatment adherence (Spiegel, 1997), and negatively 
related to cancer progression (Nausheen et al., 2009). Social support also seems to help 
cancer survivors cope with anger, stress, depression, and other indicators of 
psychological maladjustment (Holland & Holahan, 2003; Jim & Jacobsen, 2008; 
Koopman, Hermanson, Diamond, Angell, & Spiegel, 1998; Luszczynska et al., 2013; 
Nausheen et al., 2009; Salonen et al., 2012; Turner-Cobb, Sephton, Koopman, Blake-
Mortimer, & Spiegel, 2000). It is also related to workplace productivity, an outcome 
which may reflect a “return to normal” after cancer diagnosis (Nilsson et al., 2013). 
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Finally, greater social support predicts better overall QOL (Salonen et al., 2012; So et al., 
2012). In sum, social support is an important predictor of several essential outcomes in 
cancer survivors, including QOL.  
Social Functioning III: Social Constraint 
Definitions and measurement. In contrast to social support, social constraint 
reflects a negative aspect of social functioning. Lepore and Revenson (2007) define 
social constraint as “both objective social conditions and individuals’ construal of those 
conditions that lead individuals to refrain from or modify their disclosure of stress- and 
trauma-related thoughts, feelings, or concerns” (pg. 3). Social constraint is present when 
someone has an unsupportive partner, friend, or family member that responds negatively 
with criticism, avoidance, or conflict (Badr & Carmack Taylor, 2006). Of note, social 
constraint can be present in what is perceived to be a generally supportive relationship 
(Kratz et al., 2010; Pasipanodya et al., 2012), and it may even happen unintentionally 
(Pasipanodya et al., 2012). For example, a caregiver can behave in a way intended to 
communicate openness and interest, but the cancer survivor does not perceive it as such 
(Pasipanodya et al., 2012). Since social constraint can exist within the context of a 
generally positive relationship, it is important that studies of social support also measure 
social constraint. Unlike the research on social support, there is one measure of social 
constraint that is widely used across studies on the topic: the Social Constraints Scale 
(Adams, Winger, & Mosher, 2015; Lepore & Ithuarte, 1999; Lepore & Revenson, 2007; 
Pasipanodya et al., 2012). The proposed study will therefore measure social constraint 
with the aforementioned scale, so the results of this study can more easily be compared to 
those from prior studies with cancer survivors. 
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Significance. Within the context of any relationship, people who experience social 
constraint are less likely to share the events of their daily life (Pasipanodya et al., 2012) 
and therefore compromise their cognitive and emotional processing of particularly 
stressful events (Badr & Carmack Taylor, 2006; Lepore & Revenson, 2007). Thus, social 
constraint may negatively impact both individual well-being and the quality of ones 
relationship with others (i.e., relational well-being; Edwards & Clarke, 2004; Lepore & 
Revenson, 2007; Pasipanodya et al., 2012). In cancer survivors, social constraint has 
negative implications for self-esteem (Pasipanodya et al., 2012), and some indicators of 
distress (Cordova, Cunningham, Carlson, & Andrykowski, 2001), and it is expected to 
have a detrimental impact on overall QOL. 
Psychological Functioning I 
 Like social functioning, psychological functioning is a complex, multidimensional 
construct (Andrykowski et al., 2008; Ferrell et al., 1998). After cancer diagnosis, it is 
expected that most individuals will experience some degree of psychological disturbance 
(Andrykowski et al., 2008). In many cases, cancer survivors’ psychological functioning is 
expected to improve over time (Andrykowski et al., 2008; Helgeson et al., 2004). For 
those who experience an improvement, three outcomes are possible: 1) a return to a pre-
cancer baseline, or “recovery”, 2) an overall decrease in psychological functioning 
compared to the pre-cancer baseline, or “impairment”, and 3) an overall increase in 
psychological functioning compared to the pre-cancer baseline, or “growth” 
(Andrykowski et al., 2008). Thus, the psychological functioning of cancer survivors can 
follow any number of paths, some reflecting positive change, others reflecting negative 
change, and still others reflecting no change at all (i.e., “resilience”). 
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Psychological functioning includes positive and negative aspects, and it is 
important to note that said aspects are not mutually exclusive (Cordova et al., 2001). As a 
higher-order construct, psychological functioning is related to subjective reports of both 
health status (Ganz et al., 2003) and overall QOL (Tomich & Helgeson, 2012; Wenzel et 
al., 2005; Zenger et al., 2010). The positive dimensions of psychological functioning 
correspond to reports of enhanced psychological adjustment and well-being, which are 
often subsumed by the concept of posttraumatic growth (Andrykowski et al., 2008). 
Other positive psychological outcomes include benefit finding, happiness, self-esteem, 
and life satisfaction (Andrykowski et al., 2008). While such positive outcomes are indeed 
possible and clinically significant after cancer diagnosis, most research focuses on the 
negative aspects of psychological functioning. Negative psychological functioning 
mostly corresponds to reports of distress, which includes the outcomes of anxiety, worry, 
depression, sadness, anger, fear, and panic (Andrykowski et al., 2008; Ferrell et al., 
1998). Since distress is a common experience for many cancer survivors (for reviews, see 
Andrykowski et al., 2008; Carlson, Waller, & Mitchell, 2012; Jim & Jacobsen, 2008; 
Walker et al., 2012), and it too has clinically significant implications for cancer survivors 
(Andersen et al., 2008; Greer, Pirl, Park, Lynch, & Temel, 2008; Weitzner, Meyers, 
Stuebing, & Saleeba, 1997; Zenger et al., 2010), the focus of the proposed study is on 
distress. 
Psychological Functioning II: Distress 
Definitions and measurement. The experience of cancer – from diagnosis through 
treatment, recovery, and end-of-life – is widely accepted as a chronic stressor, and as 
such, it is common for cancer survivors to experience some degree of distress at some 
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point along the continuum of care (Andrykowski et al., 2008; Carlson et al., 2012). 
Distress ranges from normal feelings of vulnerability and sadness to problems that 
becomes disabling (National Comprehensive Cancer Network, 2013). There are a 
multitude of distress measures in the literature, many of which are commonly used with 
cancer survivors (e.g., Brief Symptom Inventory, General Health Questionnaire, and 
Distress Thermometer; Carlson et al., 2012). The Distress Thermometer – a single-item 
scale that taps overall distress (National Comprehensive Cancer Network, 2013) – is one 
of the most widely recommended for use with cancer survivors due to its simplicity, 
brevity, and predictive value (Carlson et al., 2012). Consequently, the proposed study 
will use the Distress Thermometer.  
Significance. A diagnosis of cancer increases the likelihood that someone 
experiences distress, even if that distress is time-limited. Around 35% of cancer survivors 
experience high levels of distress, with variation in the prevalence of “clinically 
significant” distress across the various types of cancers (Zabora, Brintzenhofeszoc, 
Curbow, Hooker, & Piantadosi, 2001). Among cancer survivors, distress has a 
detrimental impact on treatment compliance (DiMatteo, Lepper, & Croghan, 2000), 
number of medical visits (i.e., more visits), and cost of medical care (i.e., higher costs; 
Carlson & Bultz, 2004). Furthermore, distress predicts or is correlated with poorer social 
functioning (Badr, Laurenceau, Schart, Basen-Engquist, & Turk, 2010; Pasipanodya et 
al., 2012; Zakowski et al., 2003) and overall QOL in cancer survivors (Brown, Kroenke, 
Theobald, Wu, & Tu, 2010; Weitzner et al., 1997; Zenger et al., 2010). Due to its high 
prevalence and significance, more research should explore modifiable risk and protective 
factors for distress. 
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Current Study Aims 
Aim 1. Measure and describe change over time in the social functioning and 
distress of recently diagnosed cancer survivors. Three hypotheses correspond to this aim: 
a) social support will decline significantly over time; b) social constraint will not change 
significantly over time, and c) distress will not change significantly over time. 
Aim 2. Examine whether there is a longitudinal, bidirectional relationship between 
social functioning and distress in recently diagnosed cancer survivors. Three hypotheses 
correspond to this aim: a) greater social support will predict lower levels of distress, b) 
greater social constraint will predict higher levels of distress, and c) greater distress will 
predict lower levels of support and higher levels of social constraint.  
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Figure 1 
Quality of Life in Cancer Survivors (adapted from Ferrell, Dow & Grant, 1995) 
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Chapter Two: Methods 
Participants 
Participants were adults with recently diagnosed, first primary cervical or 
head/neck cancer (n=47). Since this study is part of a larger study of tobacco use after a 
new cancer diagnosis, all participants were current tobacco users based on 30-day point 
prevalence at study enrollment. Other inclusion criteria were as follows: 1) pathology-
confirmed cervical cancer or head and neck squamous cell carcinoma; 2) cancer 
diagnosis in the 6 months prior to enrollment; 3) age 21 or older at enrollment; and 4) 
ability to read, write, and understand English. Exclusion criteria were: 1) prior cancer 
diagnosis other than non-melanoma skin cancer; 2) cognitive or psychiatric impairment 
that would interfere with the ability to provide informed consent or complete study 
procedures; 3) unreliable phone access (i.e., no landline or cellular phone for personal 
use); and 4) pregnancy or plan to be pregnant within 6 months. 
Procedure 
Recruitment and enrollment.  Participants were recruited through the University 
of Kentucky Markey Cancer Center in Lexington, KY. Participants with cervical and 
head/neck cancer were recruited through the Gynecologic Oncology Clinic and 
Multidisciplinary - Head and Neck Clinic, respectively. In consultation with attending 
oncologists and nurses, research staff accessed and reviewed the electronic medical 
records of individuals scheduled for an initial evaluation to conduct a preliminary screen 
for eligibility. Those individuals not ruled out on the basis of information in their 
electronic medical record were then screened for eligibility either in person or over the 
phone. Eligible persons were briefly informed about the study procedures and asked if 
they would like to participate. If interested in study participation, these persons began the 
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process of informed consent. Individuals were “enrolled” into the study upon attainment 
of written informed consent and a signed HIPAA authorization. Prior to the 
implementation of this study, it was approved by the UK Institutional Review Board.  
Baseline assessment. Shortly after enrollment, a baseline assessment was 
conducted. Participants had the option to complete the baseline assessment via a paper-
and-pencil questionnaire (mail) or interview with research staff (over the phone or in-
person). If the questionnaire format was used for this assessment, participants received 
and returned the questionnaire by mail at no cost to them. The phone interview format 
was assisted by Research Electronic Data Capture (REDCap, Harris et al., 2009), and the 
in-person interviews were administered in clinic. Most participants completed this 
assessment via questionnaire (68.09%, n=32), with 17.02% (n=8) completing it by phone, 
and 14.89% (n=7) completing it in-person. Regardless of the method of data collection, 
the baseline assessment took 30-45 minutes to complete, and all data were entered and 
stored securely in a REDCap database. 
Daily assessment. After the baseline was completed, participants were scheduled 
to begin a 30-day period of daily assessment (i.e., 30 consecutive days of assessment). 
The preferred mode of data collection for this assessment was via phone. Instead of a 
conventional phone interview that requires interaction with research staff, the daily 
assessment was administered through the use of an interactive voice response (IVR) 
system, which is described in more detail below. IVR is an optimal approach to data 
collection since the data are securely collected and stored with a date and time stamp all 
in real time. Additionally, IVR can be used with any phone without the need for a new 
device or modification of an existing device (as is the case with some methods of daily 
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assessment, such as ecological momentary assessments). Finally, IVR has good 
acceptability and satisfaction among consumers (Corkrey & Parkinson, 2002; Mundt, 
1997), in part because it is viewed as more confidential than standard interviews (Corkrey 
& Parkinson, 2002; Kobak, Greist, Jefferson, & Katzelnick, 1996). In sum, IVR provides 
a reliable and valid means of data collection within an ecological framework. 
The IVR system used for this study was proactive, which means participants 
received an automated call at the same time each afternoon or evening, with the precise 
time dependent upon the preference of a given participant. If participants did not answer 
the call, the IVR system tried again two more times that same day according to a pre-set 
schedule of calls. Furthermore, participants also had the option to call into the IVR 
system via a 1-800 toll-free number in order to complete an assessment missed earlier in 
the day, or to proactively complete an assessment they would otherwise miss (e.g., if 
social plans conflict with their regular call schedule). The assessment itself consisted of 
20 questions in total, only five of which were of relevance to the proposed study (see 
“Daily assessment” in the Measures section below). In its entirety, this assessment took 
5.72 ± 1.09 (M ± SD) minutes to complete. During the call, participants responded to the 
IVR system via their phone’s keypad, and were able to repeat any question as needed 
before responding. 
As with the baseline assessment, participants had the option to complete this 
assessment via a paper-and-pencil questionnaire. Once again, if this format was used, 
participants received and returned the questionnaires by mail at no cost to them. Data 
obtained via questionnaire was entered and stored securely in the same system used for 
data collected via phone. While the use of a paper questionnaire is not ideal for daily 
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assessments, it was used here in an attempt to lessen the amount of missing data due to 
reasons unrelated to the research question (i.e., the practical challenges of coping with a 
chronic disease, rigorous medical procedures, and possibly even hospitalization during 
the course of the daily assessments). In the end, just under half of the daily assessments 
were completed via phone (44.73%, n=395). 
Compensation. Participants received $20 for completion of the baseline 
assessment. The compensation rate for the daily assessment was consistent with prior, 
similar studies and was designed to increase compliance with study procedures (Helzer, 
Badger, Rose, Mongeon, & Searles, 2002; Hughes et al., 2013; Peters & Hughes, 2009; 
Searles, Helzer, Rose, & Badger, 2002; Tucker et al., 2007). Thus, participants were paid 
$2 for each assessment and an additional $5 for each week where all assessments were 
completed; participants received compensation on a weekly basis for these assessments in 
order to maintain interest in this aspect of the study. In total, participants could earn up to 
$80 for the daily assessment. For both types of assessments, participants were paid via 
check. 
Measures 
Demographics. Standard items for assessment of demographic background (e.g., 
age, race, and relationship status) were used. Items were largely taken verbatim from the 
Behavioral Risk Factors Surveillance System survey (Centers for Disease Control and 
Prevention, 2011), which is a population-based health survey done annually in the United 
States. 
Chart review. A review of each participant’s electronic medical record at the 
University of Kentucky was done in order to describe the clinical characteristics of the 
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sample. These variables were extracted from each medical record, if available: 1) date of 
diagnosis; 2) age at diagnosis; 3) cancer site (e.g. larynx, oral cavity, cervical, etc.); 4) 
cancer stage; 5) date of treatment initiation; and 6) nature of treatment (e.g., surgery, 
radiation). 
Social support. Social support at baseline was primarily measured with the Duke-
UNC Functional Social Support Questionnaire (SSQ; Broadhead, Gehlbach, de Gruy, & 
Kaplan, 1988), as it taps the dimensions of perceived affective support (e.g., support 
obtained from people who give affection) and confidant support (e.g., support obtained 
through opportunities to talk about personal problems and participate in activities). The 
SSQ is often used in studies with cancer survivors (e.g., Breitbart et al., 2000; Broadhead 
& Kaplan, 1991; Bultz, Speca, Brasher, Geggie, & Page, 2000; Herndon et al., 1999; 
Osborne & Sinclair, 2004), which added to its suitability for this study. The 8-item SSQ 
has good construct, concurrent, and discriminant validity, and is sensitive to change over 
time (Broadhead et al., 1988). Example items include: “I get chances to talk to someone I 
trust about my personal and family problems” and “I get invitations to go out and do 
things with other people.” All items are measured on a scale from 1=much less than I 
would like to 5=as much as I would like. Items are scored such that higher total scores on 
the SSQ reflect greater perceived social support, and total score range from 8 to 40. The 
coefficient alpha for the SSQ was 0.92. 
  In addition to the SSQ, participants were asked to identify the one person in their 
life who they consider to be their main source of support. Response options included: 1) 
spouse or other romantic partner; 2) child; 3) other family member; 4) close friend; 5) 
member of religious organization; 6) neighbor; 7) other individual; or 8) no one (“I 
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cannot think of a support person right now”). This last question is unique to the proposed 
study, and was only used for descriptive purposes.  
Social constraint. The 15-item Social Constraints Scale (SCS;  Lepore & Ituarte, 
1999) was used to measure social responses that inhibit the expression of cancer-related 
thoughts, feelings, and experiences at baseline. This measure is the most valid and 
commonly used indicator of social constraint in studies with cancer survivors (for a 
review, see Adams et al., 2015; Lepore & Revenson, 2007). Instructions for the SCS 
directed participants to consider the behavior of other in the past month, specifically 
“with regard to [their] experience with cancer diagnosis and treatment.” Example items 
include: “Minimize your problems,” “Act uncomfortable when you talked about your 
experiences,” and “Tell you not to worry so much about your health.” All items were 
measured on a scale from 1=never to 4=often. Items were scored such that higher scores 
indicate greater social constraint, total score ranges from 15 to 60.  Coefficient alpha for 
the total score was 0.92. 
Distress. Since distress presents in many ways, two measures of distress were 
used at baseline: 1) a modified Distress Thermometer (DT) and 2) the Hospital Anxiety 
and Depression Scale (HADS). Both of these measures are discussed below.  
The 1-item DT (National Comprehensive Cancer Network, 2013), which is 
commonly used with cancer survivors (e.g., Bevans et al., 2008; Chambers et al., 2013; 
Hegel et al., 2008; Jacobsen et al., 2005), captures global distress on a 0 to 10 scale. 
Distress in cancer survivors tends to change over time, and changes in DT scores are 
positively correlated to changes in related measures (Gessler et al., 2008). Furthermore, 
DT scores demonstrate good sensitivity and specificity when measured against other self-
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report measures or structured clinical interviews (Chambers, Zajdlewicz, Youlden, 
Holland, & Dunn, 2014; Jacobsen et al., 2005; Patel, Sharpe, Thewes, Bell, & Clarke, 
2011). In addition to continuous scores, a score of ³4 is typically used as a cut-off to 
identify which cancer survivors may have clinically significant distress (Chambers et al., 
2014; Gessler et al., 2008; Jacobsen et al., 2005; Patel et al., 2011). The original measure 
asks about distress experienced in the past week, but in the proposed study, participants 
were only asked to consider their experiences on the day of the assessment. Additionally, 
the DT used in this study is on a 0 to 9 scale in order to be consistent with other items in 
the IVR assessment protocol. The item read as follows: “On a scale from 0 to 9, where 0 
is no distress and 9 is extreme distress, how much distress did you experience today?” 
The 14-item HADS (Zigmond & Snaith, 1983) measures anxiety and depressive 
symptoms, and it too is often used with cancer survivors (e.g., Patel et al., 2011; Sellick 
& Edwardson, 2007; Stafford et al., 2014). HADS anxiety and depression subscales have 
good reliability and validity (Bjelland, Dahl, Haug, & Neckelmann, 2002). In cancer 
survivors, the sensitivity and specificity for the anxiety, depression, and total scales falls 
between 70% and 90% (Bjelland et al., 2002; Patel et al., 2011; Stafford et al., 2014; Jane 
Walker et al., 2007). On the HADS, participants were asked to what extent each item (or 
symptom) describes their feelings in the past week. Example items for anxiety and 
depressive symptoms are “Worrying thoughts go through my mind” and “I have lost 
interest in my appearance,” respectively. All items were answered on a scale from 0 to 3, 
with the exact response option dependent upon the item. Items were scored such that 
higher scores represent more severe anxiety and depressive symptoms.  In addition to 
continuous scores, cut-off scores can be used to identify clinically significant distress in 
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cancer survivors, with cut-off scores that range from 7 to 11 for the depression and 
anxiety subscales (Bjelland et al., 2002; Walker et al., 2007); in this study, a score ³11 
was used as a cut-off. Coefficient alpha for the HADS total score was 0.89, and 
coefficient alpha for the anxiety and depression subscale scores were 0.85 and 0.80, 
respectively. 
Daily assessment. The daily assessment consisted of five face valid items that as a 
whole cover all key study variables (i.e., social support, social constraint, and distress). 
Each item asked about participants’ experience the day of the assessment. Additionally, 
all items were measured on a 0 to 9 scale; higher scores indicate more social support (the 
only favorable outcome), more social constraint, and more distress. Social support and 
social constraint were each measured with a single item while distress was measured with 
three items that separately tap global distress, anxiety, and depressive symptoms (see 
Table 2.1). The 1-item DT was used to measure distress in the daily assessment. Each of 
the others items used in the daily assessment were adapted from, and/or reflects the basic 
idea within, the more comprehensive measures described above.  
Although it is generally preferred to use multi-item measures to assess complex 
psychosocial constructs, daily assessment studies require brevity for compliance. The 
items in this study, therefore, converge with the approach used in similar daily 
assessment studies (e.g., (Searles et al., 2002; Zhou et al., 2009). To evaluate how well 
the single items related to their corresponding multi-item measures at baseline, Pearson’s 
r bivariate correlations were conducted. The single-item measures for social support 
(r=.54, p<.001), anxiety symptoms (r=.73, p<.001), and depressive symptoms (r=.58, 
p<.001) all exhibited strong and positive associations with their respective multi-item 
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measures. In contrast, while the single-item social constraint measure was significantly 
and positively correlated with its corresponding multi-item measure, the strength of the 
relationship was relatively weak (r=.31, p=.04). Finally, and as noted above, there was 
not a multi-item measure of distress available for comparison with the modified DT.  
Data Analysis 
Basic descriptive statistics (e.g., means, frequencies) and preliminary analyses 
(e.g., bivariate Pearson’s r correlations) were used to describe the sample’s basic 
characteristics and the relationships among all study variables at baseline. Statistical 
analysis focused on data collected via the daily assessment. 
As expected, missing data were present in the daily assessment due to the high 
demand of study participation (i.e., daily assessments for one month) and the nature of 
participants in the study (i.e., recently diagnosed cancer survivors undergoing and/or 
recovering from arduous treatments). As a result, the possibility of bias was analyzed by 
exploring baseline group differences on key study variables between participants with 
(78.72%, n=37) and without (21.28%, n=10) daily assessment data; independent samples 
t-tests and chi-square analyses were conducted, as appropriate. No significant differences 
were found on any measure of participants’ demographic background (Table 2.2), clinical 
characteristics (Table 2.3), social functioning (Table 2.4), or distress (Table 2.4). To 
explore whether there were significant differences across participants who completed 
varying amounts of the daily assessment, t-tests and chi-square analyses were again 
conducted, as appropriate. With only one exception, no significant differences were 
found on any of the aforementioned measures (data not shown). The exception was for 
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the single-item anxiety measure: participants with higher anxiety levels completed a 
smaller number of assessments (p=.04). 
For the primary analyses, multilevel modeling was used due to the nature of 
intensive longitudinal data (Bolger & Laurenceau, 2013; Singer & Willett, 2003). For 
Aim 1, slopes of change in social functioning (i.e., social support and social constraint) 
and distress from the first to the last day of the daily assessment were examined using a 
series of unconditional random intercept and slope multilevel linear models. Linear 
models were chosen because visual depiction of the raw data was not strongly suggestive 
of a curvilinear pattern of change. For ease of interpretation, the first day of daily 
assessment data was coded as zero (days coded as 0 – 29). For Aim 2, conditional 
multilevel linear models were used to identify the bidirectional relationship between day-
to-day changes in social functioning and distress. In these models, if a predictor 
variable’s slope of change did not significantly differ across the 30 days, person-centered 
means scores on the predictor were used in the model. Further, if the dependent variable’s 
slope did not change significantly over time in the unconditional models, time was re-
centered at the mid-point of the daily assessment (i.e., day 15) to establish a “typical day” 
for the dependent variable. For both aims, restricted maximum likelihood estimation was 
used to handle missing data, and data analysis was done with version 24 of the Statistical 
Package for the Social Sciences (SPSS) (IBM Corp., 2017). 
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Table 2.1 
Daily Assessment Measures 
Variable Item Scale 
Social Support  “How much support did 
you receive from others 
today?” 
0=none to 9=a great deal 
Social Constraint “How often did others 
dismiss your concerns 
when you tried to express 
them today?” 
0=never to 9=almost all the 
time 
Distress   
Global distress “How much distress did 
you experience today?” 
0=no distress to 9=extreme 
distress 
Anxiety symptoms “How often did you feel 
worried, tense, or anxious 
today?” 
0=never to 9=almost all the 
time 
Depressive symptoms “How often did you feel 
sad, blue, or depressed 
today?” 
0=never to 9=almost all the 
time 
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Table 2.2 
Demographic Characteristics of the Sample 
  Daily assessment data 
Variables 
Total sample 
(n=47) Yes (n=37) No (n=10) p 
Age in years 1 56.43 ± 7.42 55.89 ± 8.01 58.40 ± 4.43 .35 
Gender     
Male 63.83 59.46 80.00 .23 
Female 36.17 40.54 20.00  
Race     
White, non-Hispanic 95.74 94.59 100.00 .75 
African American 2.13 2.70 0.00  
Hispanic/Latino 0.00 0.00 0.00  
Other 2.13 2.70 0.00  
Relationship status     
Single, never married 8.51 8.11 10.00 .89 
Divorced, widowed, 
separated 
44.68 43.24 50.00  
Married or partnered 46.81 48.65 40.00  
Educational attainment     
Less than high school 
graduate or 
equivalent 
34.04 32.43 40.00 .87 
High school graduate or 
equivalent  
40.43 40.54 40.00  
Some college or college 
graduate 
25.53 27.03 20.00  
Employment     
Employed 21.28 21.62 20.00 .92 
Unemployed 12.77 13.51 10.00  
Disabled 51.06 48.65 60.00  
Other 2  14.89 16.22 10.00  
Annual household income     
Less than $10,000 40.43 40.54 40.00 .72 
$10,000 to $19,999 27.66 24.32 40.00  
$20,000 to $34,999 19.15 21.62 10.00  
$35,000 or more 12.77 13.51 10.00  
Note. Data are percentages unless otherwise noted. Percentages may not sum to 100.0 due 
to rounding. 1 Data are means ± standard deviations. 2 Other denotes homemaker, student, 
or retired.  
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Table 2.3 
Clinical Characteristics of the Sample 
  Daily Assessment Data 
Variable Total Sample (n=47) Yes (n=37) No (n=10) p 
Months since diagnosis 1 1.11 ± 1.71 1.27 ± 1.88 0.50  ± .53 .21 
Months since treatment 1 0.32 ± 1.42 1.05 ± 1.51 0.25  ± .50 .31 
Cancer site     
Cervical 12.77 16.22 0.00 .60 
Oral Cavity 10.64 8.11 20.00  
Larynx 34.04 32.43 40.00  
Nasal Cavity 8.51 8.11 10.00  
Pharynx  27.66 27.03 30.00  
Sinus  6.38 8.11 0.00  
Histology      
Squamous cell 
carcinoma 97.87 97.30 100.00 .60 
Adenocarcinoma 2 2.13 2.70 0.00  
Cancer stage     
0 or In situ 4.44 5.56 0.00 .53 
I 13.33 13.89 11.11  
II 15.56 19.44 0.00  
III 15.56 13.89 22.22  
IV or metastatic 51.11 47.22 66.67  
Treatment received     
Yes 91.50 94.44 90.00 .61 
No 4.26 2.78 10.00  
Not started yet treatment 4.26 2.78 0.00  
Treatment type 3      
Surgery only 16.28 17.65 11.11 .75 
Radiation only 9.30 11.76 0.00  
Surgery and radiation or 
chemotherapy 13.95 11.76 22.22  
Radiation and 
chemotherapy 41.86 41.18 44.44  
Surgery, radiation, and 
chemotherapy 18.60 17.65 22.22  
Note. Data are percentages unless otherwise noted; 1 Data are means ± standard 
deviations. 2 Only applicable to cervical cancer. 3 Data are for participants whose 
treatment was documented in their medical record at the time of data analysis (n=43).  
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Table 2.4 
Descriptive Information for Key Study Variables 
  Daily Assessment Data 
Variables Total Sample (n=47) Yes (n=37) No (n=10) 
p 
Multi-item measures     
Social Support  31.25 ± 9.00 31.54 ± 9.09 30.11 ± 9.06 .68 
Social Constraint 30.22 ± 11.01 29.31 ± 10.42 
33.78 ± 
13.15 .28 
HADS Total 14.37 ± 8.54 13.24 ± 8.04 19.00 ± 9.49 .07 
Anxiety  7.91 ± 5.01 7.22 ± 4.92 10.78 ± 4.55 .06 
Depression  6.49 ± 4.36 6.03 ± 4.04 8.20 ± 5.27 .17 
Single item measures     
Social Support 5.45 ± 3.50 5.89 ± 3.50 3.80 ± 3.12 .09 
Social Constraint  2.32 ± 3.35 2.65 ± 3.62 1.10 ± 1.66 .20 
Distress  4.32 ± 2.96 4.49 ± 2.98 3.70 ± 2.95 .46 
Anxiety 4.38 ± 3.31 4.35 ± 3.22 4.50 ± 3.84 .90 
Depression 3.57 ± 3.49 3.49 ± 3.53 3.90 ± 3.51 .74 
Note. Data are means ± standard deviations.  
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Chapter Three: Results 
Preliminary Analyses 
Sample demographic and clinical characteristics. A total of 47 participants 
completed the baseline assessment, and the details of their demographic and clinical 
background can be found in Tables 2.2 and 2.3. As a brief summary, participants’ 
average age was 56.43 ± 7.42 years old. Most participants were male (63.83%, n=30) and 
identified themselves as White non-Hispanic (95.74%, n=45). Just under half of the 
participants reported being in a relationship (46.81%, n=22). The educational attainment 
of the sample was low, with only 25.53% (n=12) reporting college education. Related to 
their employment status, most participants reported being on disability (51.06%, n=24), 
with only 21.28% (n=10) currently employed. Most participants reported an annual 
household income lower than $20,000 (67.79%, n=32). 
The sample consists of newly diagnosed cancer survivors, as indicated by the fact 
that participants’ average number of months since diagnosis at baseline was 1.11 ± 1.71. 
Most participants were diagnosed with head/neck cancer (87.23%, n=41). More than half 
of the participants were diagnosed with stage IV or metastatic cancer (51.11%, n=23). 
Most participants received some type of cancer treatment (93.48%, n=43), with many 
having multi-modal treatment (74.41%, n=32). Three participants died at some point 
during the course of the study (6.38%). Other details about participants’ clinical 
characteristics may be found in Table 2.3.  
Social functioning at baseline. Participants’ main source of support primarily 
came from their familial relationships: spouse or partner (43.48%, n=20), child (30.43%, 
n=14), and other family member (13.04%, n=6); other sources included close friends, 
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religious groups, and health professionals (13.04%, n=6). Participants’ scores on the 
SSQ, SCS and single-item social functioning measures are shown in Table 2.4. Given the 
nature of the skew, participants tended to report high levels of social support and low 
levels of social constraint. 
Distress at baseline. Participants’ continuous scores on the modified DT, HADS, 
and single-item distress measures are shown in Table 2.4; the data show a fairly normal 
distribution for each of the distress measures. In terms of the clinical significance of 
participants’ distress scores, 63.83% (n=30) of the participants met the criterion for 
significant distress on the DT. On the HADS anxiety and depression subscales, 30.43% 
(n=14) and 14.89% (n=7) of the participants reported significant anxiety and depressive 
symptoms, respectively.  
The three single-item measures of distress were significantly, positively correlated 
with each other (rs ranged from .64 to .89, all p<.001). Given this, the items were 
combined to create a composite “total” distress score. To maintain consistency across 
measures and to aid interpretation of findings, the individual distress scores were 
averaged together to create a total score that ranged from 0 to 9, with higher scores still 
indicative of greater distress. Coefficient alpha for the total distress score was 0.90. The 
average total distress score was 4.09 ± 2.97. 
Longitudinal Analyses for Unconditional Multilevel Models 
The panel plots in Figures 3.1, 3.2 and 3.3 show the within-person distribution for 
social support, social constraint, and distress, respectively. As shown, for each of these 
variables, there was relatively low variability throughout the daily assessment. 
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Table 3.1 displays the results from the unconditional growth model for social 
support and social constraint, and Table 3.2 shows the results for distress. On the first day 
of the daily assessment, participants’ average level of social support was 5.69 (SE=.51; 
p<.001), their average level of social constraint was 2.21 (SE=.36; p<.001), and their 
average level of distress was 4.25 (SE=.44; p<.001), all on a 0 to 9 scale (see the Fixed 
Effects for “Intercept”). On average, participants’ level of social support, social 
constraint, and distress did not significantly change over time (see the Fixed Effects for 
“Time”). However, a significant random effect of intercept was found for each of these 
variables, which indicates participants’ starting level of social support, social constraint, 
and distress differed across people (see the Random Effects for “Intercept”). For each 
model, no significant individual variability in slopes was identified (see the Random 
Effects for “Time”). Finally, it was also found that an individual’s level of distress on the 
first day was related to his or her change in distress over time (r=.06, p=.01). This means 
that distress increased more over time among individuals with higher distress during the 
first day. In contrast to distress, an individual’s level of social support and social 
constraint on the first day was not associated with changes in his or her respective social 
support and social constraint over time (r=.04, p=.16 and r=.03, p=.18).  
Longitudinal Analyses for Conditional Multilevel Models 
For each conditional multilevel model, person-centered mean scores were used 
for each predictor and time was centered at the mid-point (i.e., day 15), given that the 
dependent variables did not change significantly over time in the unconditional models. 
Average level of social support was unrelated to distress on a typical day (p=.42), 
and average level of distress was unrelated to social support on a typical day (p=.36); see 
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the Fixed Effects for “Social Support” and “Distress” in Table 3.3. In contrast, a 
significant, positive association was found between participants’ average level of social 
constraint and distress on a typical day, with this effect observed in both directions (see 
the Fixed Effects for “Social Constraint” and “Distress” in Table 3.4). The model for 
distress suggest that for a person who is one unit higher in social constraint on average, 
her or his typical level of distress on the 0 to 9 scale increases by .83 units (SE=.16; 
p<.001). Similarly, the model for social constraint indicates that for a person who is one 
unit higher in average distress, her or his typical level of social constraint on that same 
scale increases by .53 units (SE=.10; p<.001). Social support and social constraint were 
unrelated to change in distress and distress was unrelated to change in social support and 
social constraint (p-values ranged from .21 to .94); see the Fixed Effects for “Social 
Support by Time” and “Distress by Time” in Table 3.3, and for “Social Constraint by 
Time” and “Distress by Time” in Table 3.4. 
  
 
 32 
Table 3.1 
Parameter Estimates for the Linear Growth Model of Social Functioning 
Social Support     
    95% CI 
Fixed Effects (intercept, 
slopes) Estimate (SE) t(36) p Lower Upper 
Intercept (level at day 0) 5.69 (0.51) 11.15 .00 4.66 6.73 
Time1 0.00 (0.01) 0.31 .78 -0.02 0.03 
    95% CI 
Random Effects Estimate (SE) z p Lower Upper 
Level 2 (between-person)      
Intercept 8.98 (2.26) 3.98 .00 5.48 14.70 
Time -0.04 (0.04) -1.20 .23 -0.12 0.03 
Level 1 (within-person)      
Residual 2.50 (0.15) 16.74 .00 2.22 2.81 
Autocorrelation 0.30 (0.04) 7.16 .00 0.21 0.38 
Social Constraint     
    95% CI 
Fixed Effects (intercept, 
slopes) Estimate (SE) t(36) p Lower Upper 
Intercept (level at day 0) 2.21 (0.36) 6.13 .00 1.48 2.94 
Time1 -0.01 (0.01) -0.46 .65 -0.03 0.02 
    95% CI 
Random Effects Estimate (SE) z p Lower Upper 
Level 2 (between-person)      
Intercept 4.12 (1.13) 3.63 .00 2.40 7.07 
Time -0.01 (0.02) -0.34 .74 -0.05 0.04 
Level 1 (within-person)      
Residual 3.47 (0.18) 19.16 .00 3.13 3.84 
Autocorrelation 0.10 (0.04) 2.53 .01 0.02 0.18 
Note. CI = confidence interval; 1 Time is coded where Day 1 = 0 … Day 30 = 29
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Table 3.2 
Parameter Estimates for the Linear Growth Model of Distress 
    95% CI 
Fixed Effects (intercept, 
slopes) Estimate (SE) t(36) p Lower Upper 
Intercept (level at day 0) 4.25 (0.44) 9.63 .00 3.36 5.15 
Time1 0.13 (0.01) 0.93 .36 -0.01 0.04 
    95% CI 
Random Effects Estimate (SE) z p Lower Upper 
Level 2 (between-person)      
Intercept 6.61 (1.71) 3.88 .00 3.99 10.96 
Time -0.02 (0.04) -0.49 .63 -0.10 0.06 
Level 1 (within-person)      
Residual 1.98 (0.12) 15.92 .00 1.75 2.24 
Autocorrelation 0.37 (0.04) 9.69 .00 0.29 0.44 
Note. CI = confidence interval; 1 Time is coded where Day 1 = 0 … Day 30 = 29 
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Table 3.3 
Parameter Estimates for the Linear Growth Model of Distress as a Function of Social 
Support and Vice Versa 
Social Support à Distress     
    95% CI 
Fixed Effects (intercept, 
slopes) Estimate (SE) t(34) p Lower Upper 
Intercept (level at day 15) 5.15 (0.99) 5.20 .00 3.14 7.17 
Time 1 -0.00 (0.03) -0.12 .90 -0.06 0.06 
Social Support -0.13 (0.15) -0.82 .42 -0.44 0.19 
Social Support by Time 0.00 (0.01) 0.62 .54 -0.01 0.01 
    95% CI 
Random Effects Estimate (SE) z p Lower Upper 
Level 2 (between-person)      
Intercept 6.93 (1.75) 3.97 .00 4.23 11.37 
Time 0.04 (0.04) 1.01 .32 -0.04 0.12 
Level 1 (within-person)      
Residual 1.98 (0.12) 15.93 .00 1.75 2.24 
Autocorrelation 0.37 (0.04) 9.68 .00 0.29 0.44 
 
Distress à Social Support     
    95% CI 
Fixed Effects (intercept, 
slopes) Estimate (SE) t(34) p Lower Upper 
Intercept (level at day 15) 6.47 (0.94) 6.87 .00 4.56 8.37 
Time1 0.02 (0.02) 0.85 .40 -0.03 0.06 
Distress -0.17 (0.18) -0.91 .36 -0.54 0.20 
Distress by Time -0.00 (0.01) -0.84 .41 -0.01 0.01 
    95% CI 
Random Effects Estimate (SE) z p Lower Upper 
Level 2 (between-person)      
Intercept 8.19 (2.01) 4.07 .00 5.06 13.25 
Time -0.02 (0.03) -0.55 .58 -0.08 0.05 
Level 1 (within-person)      
Residual 2.50 (0.15) 14.91 .00 2.22 2.81 
Autocorrelation 0.30 (0.04) 7.16 .00 0.21 0.38 
Note. 1 Time is centered such that Day 15 = 0 
  
 
 35 
Table 3.4 
Parameter Estimates for the Linear Growth Model of Distress as a Function of Social 
Constraint and Vice Versa 
Social Constraintà Distress     
    95% CI 
Fixed Effects (intercept, 
slopes) Estimate (SE) t(34) p Lower Upper 
Intercept (level at day 15) 2.62 (.48) 5.40 .00 1.63 3.60 
Time1 0.01 (.02) 0.55 .58 -0.03 0.05 
Social Constraint 0.83 (.16) 5.10 .00 0.50 1.16 
Social Constraint by Time 0.00 (.01) 0.08 .94 -0.01 0.01 
    95% CI 
Random Effects Estimate (SE) z p Lower Upper 
Level 2 (between-person)      
Intercept 3.88 (1.02) 3.79 .00 2.31 6.50 
Time 0.03 (0.03) 1.05 .29 -0.03 0.09 
Level 1 (within-person)      
Residual 1.98 (0.12) 15.91 .00 1.75 2.24 
Autocorrelation 0.37 (0.04) 9.69 .00 0.29 0.44 
 
Distressà Social Constraint      
    95% CI 
Fixed Effects (intercept, 
slopes) Estimate (SE) t(34) p Lower Upper 
Intercept (level at day 15) -0.17 (0.51) -0.34 .74 -1.21 0.87 
Time1 -0.02 (0.02) -1.27 .16 -0.06 0.01 
Distress 0.53 (0.10) 5.28 .00 0.32 0.74 
Distress by Time 0.01 (0.00) 1.27 .21 -0.00 0.01 
    95% CI 
Random Effects Estimate (SE) z p Lower Upper 
Level 2 (between-person)      
    Intercept 2.26 (0.60) 3.77 .00 1.34 3.80 
    Time -0.01 (0.02) -0.50 .62 -0.04 0.02 
Level 1 (within-person)      
Residual 3.47 (0.18) 19.15 .00 3.13 3.85 
Autocorrelation 0.11 (0.04) 2.57 .01 0.02 0.18 
Note. 1 Time is centered such that Day 15 = 0 
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Figure 3.1 
Panel Plots of the 30-Day Time Course of Social Support 
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Figure 3.2 
Panel Plots of the 30-Day Time Course of Social Constraint 
 
 
 
 
 
 
 
  
 
 38 
Figure 3.3 
Panel Plots of the 30-Day Time Course of Distress 
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Chapter Four: Discussion 
Drawing from a conceptual model where the sub-factors of QOL are inter-
dependent, this study explored the nature and trajectory of social functioning and distress 
in recently diagnosed cancer survivors, and how these variables are related over time. In a 
complex fashion, the average baseline level of social functioning for this sample was both 
similar to, and different from, what is generally found in the cancer survivorship 
literature. The average level of social support (SSQ) in this sample of cervical and 
head/neck cancer survivors is similar to previous studies with breast cancer survivors 
(Osborne & Sinclair, 2004), advanced cancer survivors (Applebaum et al., 2014), and 
cancer survivors who smoked at time of diagnosis (Yang et al., 2013). The latter two 
comparison samples are noteworthy given the large proportion of participants with 
advanced disease, and the fact that all participants were smokers around the time of their 
diagnosis. As it pertains to social constraint (SCS), however, it would appear that 
participants reported higher levels than what was found in studies with gynecological and 
prostate cancer survivors (Zakowski et al., 2003; Zakowski, Ramati, Morton, Johnson, & 
Flanigan, 2004). Yet, no direct comparison of social constraint can be performed due to 
no previous studies having restricted their sample to participants with a recent cancer 
diagnosis or to only cervical or head/neck cancer survivors. Overall, it seems this 
sample’s experience of social support is comparable to that found in other cancer samples 
while their experience of social constraint may be more pronounced. 
As it pertains to their average baseline level of distress, participants reported 
similar levels of distress on the modified DT as what is found in prior studies with 
recently diagnosed head/neck cancer survivors (Buchmann, Conlee, Hunt, Agarwal, & 
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White, 2013; Lewis, Salins, Kadam, & Rao, 2013). In particular, there was a close 
alignment with a study of head/neck cancer survivors who were undergoing radiotherapy 
(Lewis et al., 2013). In contrast, when compared to studies of colon and prostate cancer 
survivors, participants in this study generally reported greater distress (Chambers et al., 
2014; Patel et al., 2011). The finding of greater distress in the current sample is supported 
by a large study that evaluated level of distress by type of cancer diagnosis (Zabora et al., 
2001). In Zabora and colleagues study (2001), head/neck cancer survivors were among 
the most distressed cancer survivors, which could be explained by the very high symptom 
burden and life disruption due to the site of the cancer and the grueling nature of its 
treatment. It should be noted, however, that in that same study gynecological cancer 
survivors (which includes cervical cancer survivors) had one of the lowest levels of 
distress. Thus, the relatively high level of distress observed here on the DT might be a 
result of the sample being primarily composed of head/neck as opposed to cervical cancer 
survivors. Of course, the DT was not the only measure of distress in this study. At 
baseline, participants’ average anxiety and depression subscale scores (HADS) were 
higher than in a previous study with head/neck cancer survivors (Pandey, Devi, Thomas, 
Kumar, & Ramdas, 2007), though it should be noted that the other study had a smaller 
percent of survivors with advanced cancer. Similarly, as indexed by their average HADS 
total score, participants reported greater distress when compared to other studies with 
recently diagnosed cancer survivors (Patel et al., 2011; Stafford et al., 2014). In sum, this 
sample of recently diagnosed cervical and head/neck cancer survivors reported a baseline 
level of distress that is higher than cancer survivors in general, but perhaps what one 
would expect for cancer survivors with advanced disease and active treatment. 
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It was expected that two distinct aspects of social functioning (namely, social 
support and social constraint) would show different patterns of change during the 30-day 
daily assessment. Given that social support is often an intentional act, a reduction in 
social support might occur when survivors are believed to be doing better or have 
finished treatment and/or when supporters need to resume or reprioritize their own 
responsibilities. In contrast, because social constraint oftentimes happens unintentionally, 
supporters might routinely engage in socially constraining ways without full awareness, 
and in the absence of survivors calling direct attention to the behavior, this pattern of 
social interaction could continue indefinitely. Taken together, it was thought that as time 
passed, on average, participants would report less social support with no change in social 
constraint. Mixed support was found for the aforementioned hypotheses, as neither social 
support nor social constraint changed significantly over time. In general, previous 
longitudinal studies of cancer survivors’ social functioning–studies that usually focus on 
the domain of social support–have found that social functioning tends to stay the same 
(Badr, Pasipanodya, & Laurenceau, 2013; Berg et al., 2008; Milbury, Badr, & Carmack, 
2012; Zhou et al., 2010) or decline (De Leeuw et al., 2000; Salonen et al., 2012; 
Zakowski et al., 2004) over time. It should be noted, however, that nearly all prior 
longitudinal studies in this area rely on assessments that are spaced weeks, months, or 
even years apart, and it may be improper to compare and contrast study findings across 
arguably disparate methods. Worth mention then is that the results of this study also 
converge with those of two prior studies that used daily assessments in cancer survivors. 
Specifically, Berg and colleagues found that couples’ level of collaborative coping (i.e., 
couples’ active engagement in pooling resources, joint problem solving, and coping) did 
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not change over time and Badr and colleagues’ study found cancer survivors’ perceptions 
of social constraint (i.e., avoiding speaking to ones partner about ones thoughts and 
feelings related to cancer) also did not change over time (Badr et al., 2013; Berg et al., 
2008). That said, it is important to highlight that social support and constraint in these 
studies were specific to married cancer survivors, and the period of observation was 
much shorter than what is used here (14 days) (Badr et al., 2013; Berg et al., 2008). Thus, 
the current findings give further support to the stability of social functioning over time 
and suggest this finding is not specific to married cancer survivors, who one might expect 
to have a more reliable source of support/constraint. In summary, while it is possible that 
the “null” results observed here are due to the 30-day window being too short a time 
period to see meaningful changes in social functioning, it is also possible that social 
support and constraint do not change significantly in the acute period after cancer 
diagnosis. 
Similar to social functioning, the extent of participants’ distress (3-item total score) 
did not change significantly over time. This finding was consistent across anxiety 
symptoms, depressive symptoms, and overall distress when evaluated independently 
using a series of unconditional multilevel models (data not shown). No significant 
changes were expected given that participants were recently diagnosed with cancer 
and/or in treatment, a period of time that is well established to be associated with at least 
modest distress levels (Andrykowski et al., 2008; Carlson, Waller, Groff, Giese-davis, & 
Bultz, 2013; Zabora et al., 2001). Thus, it was expected that while some days would be 
“good,” others would be “bad,” and overall, there would be no change over time. Other 
daily assessment studies with cancer survivors have similarly found that participants 
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individual and overall psychological functioning, does not change significantly over time 
(Berg et al., 2008; Sherliker & Steptoe, 2000). For example, the experience of negative 
emotion in prostate cancer survivors (who for the most part were recently diagnosed) did 
not change over a 14-day period (Berg et al., 2008), and recently diagnosed metastatic 
cancer survivors’ reports of psychological well-being also did not change across four 
weeks of treatment (Sherliker & Steptoe, 2000). More traditional longitudinal studies 
have found conflicting results related to cancer survivors’ long-term psychological 
functioning, such that at the present time, no singular pattern of change can be established 
across individuals (Carlson et al., 2013; de Graeff et al., 2000a; De Leeuw et al., 2000; 
Ferrandina et al., 2012; Hammerlid, Silander, Hornestam, & Sullivan, 2001; Mantegna et 
al., 2013; Neilson et al., 2010). As it pertains to head/neck and cervical cancer survivors 
specifically, some studies show an increase in distress (Neilson et al., 2010), others show 
a decrease in distress (De Leeuw et al., 2000), and still others show no change in distress 
(de Graeff et al., 2000a; Neilson et al., 2010). Overall, and akin to the results for social 
functioning, the “null” results for psychological functioning could be attributed to the 
study’s methodology or to head/neck and cervical cancer survivors simply not 
experiencing any meaningful changes in distress so soon after cancer diagnosis. 
In a QOL framework where the sub-factors are inter-dependent, it is expected that 
disruption (or improvement) in one QOL factor will negatively (or positively) affect other 
QOL factors (Bloom et al., 2007). Thus, a bidirectional, longitudinal relationship between 
social functioning and distress was hypothesized. In short, there was only modest support 
for this hypothesis. On the one hand, social constraint and distress did demonstrate a 
significant bidirectional relationship; no such relationship was observed for social support 
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and distress. On the other hand, there was no evidence (in either direction) of a 
longitudinal relationship between either social constraint or social support and distress. 
This means that while there was support for a connection between social constraint and 
distress on a typical day, there was no evidence that a change in distress from one day to 
the next was dependent upon a change in social constraint or vice versa. The lack of a 
longitudinal association is most easily explained by the fact that there was little to no 
change in these variables during the study period, which of course, makes change very 
difficult to predict. 
It is important to consider these results in light of prior research. To date, more 
studies with cancer survivors have evaluated the longitudinal relationship between social 
support and distress (Alferi, Carver, Antoni, Weiss, & Durán, 2001; Badr, Laurenceau, 
Schart, Basen-Engquist, & Turk, 2010; Berg et al., 2008; Devine, Parker, Fouladi, & 
Cohen, 2003; Luszczynska et al., 2013; Roberts, Lepore, & Helgeson, 2006; Schroevers 
et al., 2003; Zhou et al., 2010) than social constraint and distress (Pasipanodya et al., 
2012; Zakowski et al., 2004). Furthermore, of the available longitudinal studies, only 
three have investigated these relationships through daily assessment, and in all cases only 
unidirectional relationships were tested (e.g., social support predicts distress, Badr et al., 
2010; Berg et al., 2008; Pasipanodya et al., 2012). Across studies, social support shows 
an inconsistent relationship with distress (Carpenter, Fowler, Maxwell, & Andersen, 
2010; de Graeff et al., 2000a; De Leeuw et al., 2000; Naughton et al., 2002; Schmidt & 
Andrykowski, 2004; Smith et al., 2012) while social constraint is consistently, positively 
correlated with distress (Badr et al., 2013; Chambers et al., 2015; Cordova et al., 2001; 
Eton, Lepore, & Helgeson, 2001; Lepore & Helgeson, 1998; Nenova, Duhamel, Zemon, 
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Rini, & Redd, 2013; Schmidt & Andrykowski, 2004; Zakowski et al., 2003). In the few 
head-to-head comparisons, social constraint has shown a stronger relationship with 
distress than social support (Eton et al., 2001; Nenova et al., 2013; Schmidt & 
Andrykowski, 2004), possibly because its effect is universal. In other words, constraining 
behavior is detrimental to any and all cancer survivors, such that a lot of constraint is 
always “bad” and little to no constraint is always “good.” Similarly, the experience of 
distress (because it is usually perceived as “bad”) might incite social constraint from 
others. In contrast to social constraint, the modest role for social support in general could 
be because its receipt is psychologically beneficial for some while harmful for others (De 
Leeuw et al., 2000), essentially washing out its effect at the sample or population level. 
Even if that is the case, though, one might still expect a within-person association 
between distress and social support, as is sometimes found (Badr et al., 2010).  In sum, a 
bidirectional positive relationship was found for social constraint and distress, and 
suggests that opportunities for cancer survivors to share their emotions and experiences 
may be important for distress management and likewise that the experience of distress 
may contribute to a “closed” or “constraining” social environment. 
To our knowledge, no study published to date involves the same intensity and 
duration of naturalistic observations of social and/or psychological functioning after 
cancer diagnosis. Of the few other daily assessment studies in this area, they either 
include a smaller sample size than what was used here (Sherliker & Steptoe, 2000), 
involve a shorter period of observation, are not restrictive to those newly diagnosed with 
cancer (Badr et al., 2013; Berg et al., 2008), or do not evaluate the trajectory of change in 
the outcome (Badr et al., 2010; Fagundes, Berg, & Wiebe, 2012; Pasipanodya et al., 
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2012). In addition, it is important to highlight that nearly half of participants in this study 
had stage IV disease, whereas other daily assessment studies only include survivors with 
less advanced disease (e.g., Belcher et al., 2011; Berg et al., 2008; Pasipanodya et al., 
2012). Thus, this study attempts to tackle many of the methodological shortcomings of 
prior studies. 
Despite its innovation and methodological rigor, this study is not without its 
limitations. First, the sample size is small, even for a data analytic approach that is 
designed to capitalize on the richness of intensive longitudinal data collection. That said, 
given the expectation of 30 consecutive days of assessment, the high symptom burden 
and arduous nature of cancer treatment, plus the stigma sometimes associated with 
smoking-related cancers, we anticipated a small sample size with a high degree of 
dropout. Nonetheless, the small sample size prohibited inclusion of covariates in the 
multivariate models, and it also prohibited the inclusion of both social support and social 
constraint as predictors of distress in the same model. Second, given that daily 
assessment studies require brevity for compliance, some of the key variables were 
measured with only one item, which is not ideal for complex psychosocial constructs. 
There is, of course, precedence for single item measures in daily assessment studies (e.g., 
Badr et al., 2010, 2013; Berg et al., 2008; Pasipanodya et al., 2012; Searles et al., 2002; 
Zhou et al., 2009), and more importantly, all of the single-item measures in this study 
were significantly associated with their respective multi-item measures at baseline, which 
suggest the single-item measures are targeting the same construct. Third, the null findings 
related to social support could be attributed to it being measured as too general as 
construct, as social support is known to be multidimensional (Dakof & Taylor, 1990; 
 
 47 
Nausheen et al., 2009; Schroevers et al., 2010). Future studies should therefore include 
more specific dimensions of social support in an attempt to determine which, if any, 
dimensions change over time and are more strongly associated with distress (e.g., 
availability of support if needed, extent of social network). Fourth, the DT measure was 
modified from a 0-10 scale to 0-9 scale to avoid errors in data capture within the IVR 
system (i.e., a “10” is recognized/entered as a “1”). Due to this modification, the direct 
comparison between the DT results of this study and those of past and future studies that 
use the DT is somewhat limited. Fifth, participants who had the highest amounts of 
missing data during the daily assessment reported the highest anxiety levels at baseline, 
which could have implications for the generalizability of the results. However, given that 
restricted maximum likelihood estimator uses all available data to estimate any missing 
data, it is expected that the estimated data are a good proxy for the real values. Lastly, 
participants’ demographic and clinical characteristics may limit the generalizability of 
study findings.  
In summary, this study provides a greater understanding of two central aspects of 
QOL during the acute period of cancer diagnosis and treatment, namely social and 
psychological functioning. The results showed little change in social support, social 
constraint, and distress among recently diagnosed head/neck and cervical cancer 
survivors, results that may generalize to other cancer populations, in particular those with 
advanced disease and ensuing treatment. Of course, it might be the case that meaningful 
changes in social functioning and distress are in fact present among recently diagnosed 
cancer survivors, it is just that these changes are confined to a single day. If so, 
observation of change would require ecological momentary assessment, which was not 
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used here. It might also be the case that change in these constructs unfolds more slowly, 
over weeks or even months, in which case the more traditional approaches to longitudinal 
studies would be appropriate. For these reasons, it is not yet possible to “close the book” 
on changes in social functioning and distress after cancer diagnosis. Future studies are 
still needed to unpack the complexity of how cancer diagnosis might impact these QOL 
components. In addition to the results related to change over time (or the lack thereof), 
this study also showed that for a typical day, social constraint–but not social support–
predicts distress and vice versa. These findings underscore the need to consider both 
positive and negative aspects of cancer survivors’ social functioning in attempts to 
predict or explain their psychological functioning, at least as it pertains to the outcome of 
distress. Furthermore, these findings support existing theories, which purport that social 
functioning is multidimensional and its sub-components differentially impact distress. In 
conclusion, this study further highlights the importance of social functioning and distress 
after cancer diagnosis, and raises the possibility that improvements in one QOL domain 
may be achieved through improvements in another, related QOL domain. 
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